Structure

Physi-Chem Properties

Molecular Weight:  462.08
Volume:  413.381
LogP:  0.517
LogD:  0.237
LogS:  -5.098
# Rotatable Bonds:  3
TPSA:  189.26
# H-Bond Aceptor:  12
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.204
Synthetic Accessibility Score:  4.32
Fsp3:  0.333
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.291
MDCK Permeability:  3.2966661819955334e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.584
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.977

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.032
Plasma Protein Binding (PPB):  72.94428253173828%
Volume Distribution (VD):  0.965
Pgp-substrate:  30.092599868774414%

ADMET: Metabolism

CYP1A2-inhibitor:  0.329
CYP1A2-substrate:  0.736
CYP2C19-inhibitor:  0.019
CYP2C19-substrate:  0.165
CYP2C9-inhibitor:  0.053
CYP2C9-substrate:  0.311
CYP2D6-inhibitor:  0.025
CYP2D6-substrate:  0.144
CYP3A4-inhibitor:  0.074
CYP3A4-substrate:  0.008

ADMET: Excretion

Clearance (CL):  1.488
Half-life (T1/2):  0.763

ADMET: Toxicity

hERG Blockers:  0.005
Human Hepatotoxicity (H-HT):  0.961
Drug-inuced Liver Injury (DILI):  0.992
AMES Toxicity:  0.372
Rat Oral Acute Toxicity:  0.053
Maximum Recommended Daily Dose:  0.141
Skin Sensitization:  0.696
Carcinogencity:  0.037
Eye Corrosion:  0.004
Eye Irritation:  0.051
Respiratory Toxicity:  0.069

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC34436

Natural Product ID:  NPC34436
Common Name*:   IAYGIELPGJHKME-UKZWKHHHSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  IAYGIELPGJHKME-UKZWKHHHSA-N
Standard InCHI:  InChI=1S/C21H18O12/c1-5-12(23)14(25)15(26)21(30-5)31-9-4-7-10-11-6(19(27)32-17(10)13(9)24)3-8(22)16(29-2)18(11)33-20(7)28/h3-5,12,14-15,21-26H,1-2H3/t5-,12-,14+,15+,21-/m0/s1
SMILES:  C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)Oc1cc2c3c4c(cc(c(c4oc2=O)OC)O)c(=O)oc3c1O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL460463
PubChem CID:   44560360
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33358 phyllanthus acutissima Species n.a. Eukaryota aerial parts n.a. n.a. PMID[18271551]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT459 Individual Protein Human immunodeficiency virus type 1 reverse transcriptase Human immunodeficiency virus 1 Inhibition = -9.2 % PMID[546576]
NPT1034 Cell Line Lu1 Homo sapiens ED50 > 5.0 ug ml-1 PMID[546576]
NPT83 Cell Line MCF7 Homo sapiens ED50 > 5.0 ug ml-1 PMID[546576]
NPT1851 Cell Line Col2 Homo sapiens ED50 > 5.0 ug ml-1 PMID[546576]
NPT91 Cell Line KB Homo sapiens ED50 > 5.0 ug ml-1 PMID[546576]
NPT168 Cell Line P388 Mus musculus ED50 > 5.0 ug ml-1 PMID[546576]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 > 125.0 ug.mL-1 PMID[546576]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 IC50 > 125.0 ug.mL-1 PMID[546576]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 > 5.0 ug ml-1 PMID[546576]
NPT20950 CELL-LINE Erythrocyte n.a. IC50 = 180000.0 nM PMID[546577]
NPT20950 CELL-LINE Erythrocyte n.a. IC50 = 260000.0 nM PMID[546577]
NPT20950 CELL-LINE Erythrocyte n.a. MIC = 340000.0 nM PMID[546577]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC34436 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC263119
1.0 High Similarity NPC46640
1.0 High Similarity NPC219600
1.0 High Similarity NPC166674
0.9877 High Similarity NPC473550
0.9876 High Similarity NPC181778
0.9693 High Similarity NPC38438
0.9636 High Similarity NPC297574
0.9408 High Similarity NPC123259
0.9408 High Similarity NPC129533
0.9405 High Similarity NPC80956
0.9349 High Similarity NPC208797
0.9349 High Similarity NPC53680
0.9317 High Similarity NPC40702
0.9317 High Similarity NPC267627
0.9317 High Similarity NPC37502
0.9286 High Similarity NPC472723
0.9259 High Similarity NPC24627
0.9255 High Similarity NPC247713
0.9244 High Similarity NPC237202
0.9191 High Similarity NPC173872
0.9191 High Similarity NPC477083
0.9191 High Similarity NPC477081
0.9191 High Similarity NPC119094
0.9191 High Similarity NPC269046
0.9172 High Similarity NPC473713
0.9172 High Similarity NPC67629
0.9172 High Similarity NPC79736
0.9167 High Similarity NPC163165
0.9157 High Similarity NPC298847
0.9141 High Similarity NPC239966
0.9141 High Similarity NPC203020
0.9136 High Similarity NPC1913
0.9118 High Similarity NPC267549
0.9102 High Similarity NPC183036
0.9102 High Similarity NPC229687
0.9091 High Similarity NPC121290
0.908 High Similarity NPC142291
0.908 High Similarity NPC160780
0.908 High Similarity NPC7839
0.908 High Similarity NPC289811
0.9075 High Similarity NPC261623
0.9075 High Similarity NPC111490
0.9068 High Similarity NPC116850
0.9068 High Similarity NPC144801
0.9068 High Similarity NPC178134
0.9068 High Similarity NPC238672
0.9068 High Similarity NPC197188
0.9068 High Similarity NPC43872
0.9068 High Similarity NPC291510
0.9053 High Similarity NPC239549
0.9053 High Similarity NPC51774
0.9053 High Similarity NPC236191
0.9048 High Similarity NPC51326
0.9048 High Similarity NPC105095
0.9048 High Similarity NPC474434
0.9048 High Similarity NPC44328
0.9048 High Similarity NPC231194
0.9048 High Similarity NPC177731
0.9048 High Similarity NPC79056
0.9042 High Similarity NPC116745
0.9042 High Similarity NPC249977
0.9042 High Similarity NPC45400
0.9042 High Similarity NPC473818
0.903 High Similarity NPC285108
0.903 High Similarity NPC33298
0.903 High Similarity NPC14030
0.903 High Similarity NPC148273
0.903 High Similarity NPC291957
0.9029 High Similarity NPC93065
0.9029 High Similarity NPC472721
0.9029 High Similarity NPC31208
0.9029 High Similarity NPC187632
0.9029 High Similarity NPC469652
0.9029 High Similarity NPC160543
0.9029 High Similarity NPC472724
0.9029 High Similarity NPC472720
0.9024 High Similarity NPC166277
0.9024 High Similarity NPC119125
0.9018 High Similarity NPC472860
0.9018 High Similarity NPC474010
0.9018 High Similarity NPC135222
0.9017 High Similarity NPC231254
0.9012 High Similarity NPC170203
0.9012 High Similarity NPC8940
0.9012 High Similarity NPC125352
0.9006 High Similarity NPC476620
0.9006 High Similarity NPC472387
0.9006 High Similarity NPC476623
0.9006 High Similarity NPC476618
0.9006 High Similarity NPC476619
0.9006 High Similarity NPC476622
0.9006 High Similarity NPC476621
0.9 High Similarity NPC142996
0.8994 High Similarity NPC472386
0.8994 High Similarity NPC156977
0.8994 High Similarity NPC267254
0.8994 High Similarity NPC47140
0.8994 High Similarity NPC301683
0.8994 High Similarity NPC67134
0.8988 High Similarity NPC61791
0.8988 High Similarity NPC658
0.8988 High Similarity NPC197708
0.8988 High Similarity NPC43587
0.8988 High Similarity NPC293629
0.8988 High Similarity NPC210042
0.8988 High Similarity NPC95855
0.8983 High Similarity NPC477082
0.8982 High Similarity NPC236934
0.8982 High Similarity NPC5778
0.8977 High Similarity NPC264302
0.8976 High Similarity NPC67959
0.8976 High Similarity NPC470898
0.8971 High Similarity NPC223534
0.8971 High Similarity NPC158214
0.8971 High Similarity NPC290289
0.8971 High Similarity NPC240200
0.897 High Similarity NPC472859
0.897 High Similarity NPC25389
0.897 High Similarity NPC311803
0.8966 High Similarity NPC469650
0.8963 High Similarity NPC87317
0.8953 High Similarity NPC212290
0.8944 High Similarity NPC228662
0.8941 High Similarity NPC175230
0.8941 High Similarity NPC472993
0.8941 High Similarity NPC172033
0.8941 High Similarity NPC88560
0.8935 High Similarity NPC52598
0.8935 High Similarity NPC183357
0.8935 High Similarity NPC224462
0.8935 High Similarity NPC22195
0.8935 High Similarity NPC21190
0.8935 High Similarity NPC34287
0.8935 High Similarity NPC149011
0.8935 High Similarity NPC471416
0.8935 High Similarity NPC470272
0.8935 High Similarity NPC204937
0.8935 High Similarity NPC44558
0.8929 High Similarity NPC311389
0.8929 High Similarity NPC229729
0.8929 High Similarity NPC93099
0.8929 High Similarity NPC477502
0.8929 High Similarity NPC470271
0.8922 High Similarity NPC99216
0.8922 High Similarity NPC165720
0.8922 High Similarity NPC7752
0.892 High Similarity NPC201814
0.8916 High Similarity NPC41009
0.8914 High Similarity NPC65489
0.8914 High Similarity NPC105591
0.8914 High Similarity NPC469649
0.8914 High Similarity NPC260521
0.8909 High Similarity NPC24164
0.8909 High Similarity NPC53889
0.8909 High Similarity NPC289346
0.8895 High Similarity NPC120952
0.8889 High Similarity NPC169645
0.8889 High Similarity NPC63105
0.8889 High Similarity NPC102028
0.8889 High Similarity NPC310661
0.8889 High Similarity NPC105827
0.8889 High Similarity NPC84482
0.8882 High Similarity NPC307518
0.8882 High Similarity NPC5786
0.8882 High Similarity NPC254540
0.8882 High Similarity NPC102851
0.8882 High Similarity NPC256760
0.8882 High Similarity NPC172807
0.8882 High Similarity NPC48773
0.8882 High Similarity NPC205076
0.8882 High Similarity NPC211594
0.8876 High Similarity NPC471457
0.8876 High Similarity NPC195257
0.8876 High Similarity NPC472381
0.8876 High Similarity NPC105283
0.8876 High Similarity NPC112755
0.8876 High Similarity NPC170675
0.8876 High Similarity NPC209296
0.8876 High Similarity NPC472383
0.887 High Similarity NPC471091
0.887 High Similarity NPC97924
0.887 High Similarity NPC40078
0.8869 High Similarity NPC210073
0.8869 High Similarity NPC175793
0.8869 High Similarity NPC115674
0.8862 High Similarity NPC284960
0.8862 High Similarity NPC222936
0.8862 High Similarity NPC88043
0.8862 High Similarity NPC29830
0.8848 High Similarity NPC74319
0.8848 High Similarity NPC287872
0.8844 High Similarity NPC84494
0.8844 High Similarity NPC245059
0.8841 High Similarity NPC88803
0.8841 High Similarity NPC300845
0.8841 High Similarity NPC250436
0.8841 High Similarity NPC471405
0.8841 High Similarity NPC104983
0.8841 High Similarity NPC291948

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC34436 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9068 High Similarity NPD1465 Phase 2
0.9048 High Similarity NPD7074 Phase 3
0.8876 High Similarity NPD7054 Approved
0.8841 High Similarity NPD4868 Clinical (unspecified phase)
0.8824 High Similarity NPD7472 Approved
0.8706 High Similarity NPD3818 Discontinued
0.8671 High Similarity NPD4338 Clinical (unspecified phase)
0.8663 High Similarity NPD6797 Phase 2
0.8655 High Similarity NPD5844 Phase 1
0.8613 High Similarity NPD7251 Discontinued
0.8596 High Similarity NPD7228 Approved
0.8563 High Similarity NPD7808 Phase 3
0.8555 High Similarity NPD7993 Clinical (unspecified phase)
0.848 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.848 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.848 Intermediate Similarity NPD6166 Phase 2
0.8452 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD1934 Approved
0.8294 Intermediate Similarity NPD6234 Discontinued
0.8229 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD37 Approved
0.8198 Intermediate Similarity NPD7199 Phase 2
0.8193 Intermediate Similarity NPD1653 Approved
0.8176 Intermediate Similarity NPD4966 Approved
0.8176 Intermediate Similarity NPD4965 Approved
0.8176 Intermediate Similarity NPD4967 Phase 2
0.8166 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.815 Intermediate Similarity NPD6232 Discontinued
0.8092 Intermediate Similarity NPD6959 Discontinued
0.809 Intermediate Similarity NPD6559 Discontinued
0.809 Intermediate Similarity NPD7240 Approved
0.809 Intermediate Similarity NPD7685 Pre-registration
0.8077 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD2801 Approved
0.8012 Intermediate Similarity NPD3817 Phase 2
0.8011 Intermediate Similarity NPD7473 Discontinued
0.8 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD8312 Approved
0.8 Intermediate Similarity NPD8313 Approved
0.7989 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD3882 Suspended
0.7953 Intermediate Similarity NPD7819 Suspended
0.7931 Intermediate Similarity NPD5494 Approved
0.7927 Intermediate Similarity NPD8151 Discontinued
0.7919 Intermediate Similarity NPD7075 Discontinued
0.7917 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7912 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD4380 Phase 2
0.7865 Intermediate Similarity NPD3751 Discontinued
0.7849 Intermediate Similarity NPD8455 Phase 2
0.7846 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7846 Intermediate Similarity NPD7783 Phase 2
0.7805 Intermediate Similarity NPD7266 Discontinued
0.7791 Intermediate Similarity NPD6801 Discontinued
0.7771 Intermediate Similarity NPD3750 Approved
0.7746 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD3787 Discontinued
0.7738 Intermediate Similarity NPD1511 Approved
0.7737 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD230 Phase 1
0.7714 Intermediate Similarity NPD3749 Approved
0.7701 Intermediate Similarity NPD5402 Approved
0.7665 Intermediate Similarity NPD4628 Phase 3
0.7654 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD1512 Approved
0.7633 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7411 Suspended
0.7577 Intermediate Similarity NPD7435 Discontinued
0.7577 Intermediate Similarity NPD7680 Approved
0.7546 Intermediate Similarity NPD1613 Approved
0.7546 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD1549 Phase 2
0.7545 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD6799 Approved
0.7515 Intermediate Similarity NPD6190 Approved
0.7513 Intermediate Similarity NPD6779 Approved
0.7513 Intermediate Similarity NPD6782 Approved
0.7513 Intermediate Similarity NPD6777 Approved
0.7513 Intermediate Similarity NPD6778 Approved
0.7513 Intermediate Similarity NPD6776 Approved
0.7513 Intermediate Similarity NPD6780 Approved
0.7513 Intermediate Similarity NPD6781 Approved
0.75 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5403 Approved
0.7485 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD2532 Approved
0.7485 Intermediate Similarity NPD2533 Approved
0.7485 Intermediate Similarity NPD2534 Approved
0.7485 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD6599 Discontinued
0.747 Intermediate Similarity NPD3748 Approved
0.7458 Intermediate Similarity NPD7768 Phase 2
0.7414 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7398 Intermediate Similarity NPD7698 Approved
0.7398 Intermediate Similarity NPD7696 Phase 3
0.7398 Intermediate Similarity NPD7697 Approved
0.7396 Intermediate Similarity NPD6674 Discontinued
0.7384 Intermediate Similarity NPD5401 Approved
0.7384 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD919 Approved
0.7362 Intermediate Similarity NPD3027 Phase 3
0.736 Intermediate Similarity NPD8319 Approved
0.736 Intermediate Similarity NPD8320 Phase 1
0.735 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.735 Intermediate Similarity NPD7874 Approved
0.7346 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD7585 Approved
0.7337 Intermediate Similarity NPD7701 Phase 2
0.7321 Intermediate Similarity NPD2796 Approved
0.7317 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD7458 Discontinued
0.7314 Intermediate Similarity NPD3226 Approved
0.7308 Intermediate Similarity NPD3926 Phase 2
0.7301 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD8127 Discontinued
0.7289 Intermediate Similarity NPD1933 Approved
0.7289 Intermediate Similarity NPD447 Suspended
0.7287 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7286 Intermediate Similarity NPD7583 Approved
0.7283 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7871 Phase 2
0.7273 Intermediate Similarity NPD7870 Phase 2
0.7262 Intermediate Similarity NPD1510 Phase 2
0.726 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD6823 Phase 2
0.7254 Intermediate Similarity NPD6535 Approved
0.7254 Intermediate Similarity NPD6534 Approved
0.7251 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD7700 Phase 2
0.7231 Intermediate Similarity NPD7699 Phase 2
0.7213 Intermediate Similarity NPD5242 Approved
0.7211 Intermediate Similarity NPD8150 Discontinued
0.7207 Intermediate Similarity NPD5353 Approved
0.72 Intermediate Similarity NPD920 Approved
0.7158 Intermediate Similarity NPD7229 Phase 3
0.7157 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7801 Approved
0.7143 Intermediate Similarity NPD6273 Approved
0.7126 Intermediate Similarity NPD1240 Approved
0.7126 Intermediate Similarity NPD943 Approved
0.712 Intermediate Similarity NPD8434 Phase 2
0.7118 Intermediate Similarity NPD2935 Discontinued
0.7118 Intermediate Similarity NPD6100 Approved
0.7118 Intermediate Similarity NPD6099 Approved
0.7118 Intermediate Similarity NPD1551 Phase 2
0.7114 Intermediate Similarity NPD7584 Approved
0.7104 Intermediate Similarity NPD1247 Approved
0.709 Intermediate Similarity NPD7549 Discontinued
0.7083 Intermediate Similarity NPD6843 Phase 3
0.7083 Intermediate Similarity NPD6841 Approved
0.7083 Intermediate Similarity NPD6842 Approved
0.7076 Intermediate Similarity NPD2346 Discontinued
0.7065 Intermediate Similarity NPD5710 Approved
0.7065 Intermediate Similarity NPD5711 Approved
0.7041 Intermediate Similarity NPD1607 Approved
0.7037 Intermediate Similarity NPD9269 Phase 2
0.703 Intermediate Similarity NPD9494 Approved
0.7029 Intermediate Similarity NPD7390 Discontinued
0.7026 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD6212 Phase 3
0.7026 Intermediate Similarity NPD6213 Phase 3
0.7017 Intermediate Similarity NPD4288 Approved
0.7 Intermediate Similarity NPD5005 Approved
0.7 Intermediate Similarity NPD5006 Approved
0.7 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.6994 Remote Similarity NPD1652 Phase 2
0.6994 Remote Similarity NPD1243 Approved
0.6994 Remote Similarity NPD2800 Approved
0.6989 Remote Similarity NPD642 Clinical (unspecified phase)
0.6989 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6988 Remote Similarity NPD4908 Phase 1
0.6984 Remote Similarity NPD5953 Discontinued
0.6982 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6982 Remote Similarity NPD5124 Phase 1
0.6968 Remote Similarity NPD7286 Phase 2
0.6959 Remote Similarity NPD651 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7930 Approved
0.6954 Remote Similarity NPD7003 Approved
0.6947 Remote Similarity NPD7039 Approved
0.6947 Remote Similarity NPD7038 Approved
0.6944 Remote Similarity NPD6385 Approved
0.6944 Remote Similarity NPD6386 Approved
0.6944 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4060 Phase 1
0.6919 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6915 Remote Similarity NPD7177 Discontinued
0.6909 Remote Similarity NPD2797 Approved
0.6905 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6905 Remote Similarity NPD3764 Approved
0.6905 Remote Similarity NPD6798 Discontinued
0.6905 Remote Similarity NPD3268 Approved
0.6901 Remote Similarity NPD7097 Phase 1
0.6886 Remote Similarity NPD6832 Phase 2
0.6884 Remote Similarity NPD4420 Approved
0.6882 Remote Similarity NPD6355 Discontinued
0.6875 Remote Similarity NPD643 Clinical (unspecified phase)
0.6872 Remote Similarity NPD4287 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data